ArticleThrombosis journal2022

Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study.

Khalid Al Sulaiman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.